Mapacalcine protects mouse neurons against hypoxia by blocking cell calcium overload.
Stroke is one of a major cause of death and adult disability. Despite intense researches, treatment for stroke remains reduced to fibrinolysis, a technique useful for less than 10% of patients. Finding molecules able to treat or at least to decrease the deleterious consequences of stroke is an urgen...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2013-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23843951/?tool=EBI |
| _version_ | 1818575415329947648 |
|---|---|
| author | Hamid Moha Ou Maati Catherine Widmann Djamila Sedjelmaci Bernard Gallois Catherine Heurteaux Marc Borsotto Michel Hugues |
| author_facet | Hamid Moha Ou Maati Catherine Widmann Djamila Sedjelmaci Bernard Gallois Catherine Heurteaux Marc Borsotto Michel Hugues |
| author_sort | Hamid Moha Ou Maati |
| collection | DOAJ |
| description | Stroke is one of a major cause of death and adult disability. Despite intense researches, treatment for stroke remains reduced to fibrinolysis, a technique useful for less than 10% of patients. Finding molecules able to treat or at least to decrease the deleterious consequences of stroke is an urgent need. Here, we showed that mapacalcine, a homodimeric peptide purified from the marine sponge Cliona vastifica, is able to protect mouse cortical neurons against hypoxia. We have also identified a subtype of L-type calcium channel as a target for mapacalcine and we showed that the channel has to be open for mapacalcine binding. The two main L-type subunits at the brain level are CaV1.3 and CaV1.2 subunits but mapacalcine was unable to block these calcium channels.Mapacalcine did not interfere with N-, P/Q- and R-type calcium channels. The protective effect was studied by measuring internal calcium level variation triggered by Oxygen Glucose Deprivation protocol, which mimics stroke, or glutamate stimulation. We showed that NMDA/AMPA receptors are not involved in the mapacalcine protection. The protective effect was confirmed by measuring the cell survival rate after Oxygen Glucose Deprivation condition. Our data indicate that mapacalcine is a promising molecule for stroke treatment. |
| first_indexed | 2024-12-15T00:39:59Z |
| format | Article |
| id | doaj.art-cb11dc94c9884aa9bd9f780fee077e0f |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-12-15T00:39:59Z |
| publishDate | 2013-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-cb11dc94c9884aa9bd9f780fee077e0f2022-12-21T22:41:41ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-0187e6619410.1371/journal.pone.0066194Mapacalcine protects mouse neurons against hypoxia by blocking cell calcium overload.Hamid Moha Ou MaatiCatherine WidmannDjamila SedjelmaciBernard GalloisCatherine HeurteauxMarc BorsottoMichel HuguesStroke is one of a major cause of death and adult disability. Despite intense researches, treatment for stroke remains reduced to fibrinolysis, a technique useful for less than 10% of patients. Finding molecules able to treat or at least to decrease the deleterious consequences of stroke is an urgent need. Here, we showed that mapacalcine, a homodimeric peptide purified from the marine sponge Cliona vastifica, is able to protect mouse cortical neurons against hypoxia. We have also identified a subtype of L-type calcium channel as a target for mapacalcine and we showed that the channel has to be open for mapacalcine binding. The two main L-type subunits at the brain level are CaV1.3 and CaV1.2 subunits but mapacalcine was unable to block these calcium channels.Mapacalcine did not interfere with N-, P/Q- and R-type calcium channels. The protective effect was studied by measuring internal calcium level variation triggered by Oxygen Glucose Deprivation protocol, which mimics stroke, or glutamate stimulation. We showed that NMDA/AMPA receptors are not involved in the mapacalcine protection. The protective effect was confirmed by measuring the cell survival rate after Oxygen Glucose Deprivation condition. Our data indicate that mapacalcine is a promising molecule for stroke treatment.https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23843951/?tool=EBI |
| spellingShingle | Hamid Moha Ou Maati Catherine Widmann Djamila Sedjelmaci Bernard Gallois Catherine Heurteaux Marc Borsotto Michel Hugues Mapacalcine protects mouse neurons against hypoxia by blocking cell calcium overload. PLoS ONE |
| title | Mapacalcine protects mouse neurons against hypoxia by blocking cell calcium overload. |
| title_full | Mapacalcine protects mouse neurons against hypoxia by blocking cell calcium overload. |
| title_fullStr | Mapacalcine protects mouse neurons against hypoxia by blocking cell calcium overload. |
| title_full_unstemmed | Mapacalcine protects mouse neurons against hypoxia by blocking cell calcium overload. |
| title_short | Mapacalcine protects mouse neurons against hypoxia by blocking cell calcium overload. |
| title_sort | mapacalcine protects mouse neurons against hypoxia by blocking cell calcium overload |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23843951/?tool=EBI |
| work_keys_str_mv | AT hamidmohaoumaati mapacalcineprotectsmouseneuronsagainsthypoxiabyblockingcellcalciumoverload AT catherinewidmann mapacalcineprotectsmouseneuronsagainsthypoxiabyblockingcellcalciumoverload AT djamilasedjelmaci mapacalcineprotectsmouseneuronsagainsthypoxiabyblockingcellcalciumoverload AT bernardgallois mapacalcineprotectsmouseneuronsagainsthypoxiabyblockingcellcalciumoverload AT catherineheurteaux mapacalcineprotectsmouseneuronsagainsthypoxiabyblockingcellcalciumoverload AT marcborsotto mapacalcineprotectsmouseneuronsagainsthypoxiabyblockingcellcalciumoverload AT michelhugues mapacalcineprotectsmouseneuronsagainsthypoxiabyblockingcellcalciumoverload |